Resources from the same session
281MO - Quality of life and neurocognitive function in patients with active brain metastases of HER2-positive breast cancer treated with trastuzumab-deruxtecan: Secondary endpoint analysis of the prospective single-arm phase II TUXEDO-1 trial
Presenter: Angelika M. Starzer
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
282MO - Brain metastases: Real-life treatment patterns, survival and patient-reported outcomes – Results from a population-based, prospective study in 914 patients
Presenter: Olav Yri
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
283MO - Leptomeningeal disease (LMD) in patients (pts) with metastatic melanoma (MM): Survival analysis of a contemporary cohort
Presenter: Isabella Glitza
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
284MO - Targeting the tumor microenvironment of glioblastoma multiforme using a macrophage-based treatment for the local delivery of immune-therapeutic payload: The TEM-GBM study (NCT03866109)
Presenter: Gaetano Finocchiaro
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
285MO - The combination of lomustine and antibody-based targeted TNF (L19TNF) as a promising treatment for recurrent glioblastoma
Presenter: Tobias Weiss
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
286MO - Radiomics-based prediction of lymphocyte infiltration in IDH-wildtype glioblastoma
Presenter: Maximilian Mair
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 284MO, 285MO and 286MO
Presenter: Monika Hegi
Session: Mini Oral session: CNS tumours
Resources:
Slides
Webcast
287MO - A phase 0 ‘trigger’ trial of pamiparib in newly diagnosed and recurrent glioblastoma patients
Presenter: Nader Sanai
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
288MO - Brain-only oligometastatic cancer patients present with longer overall survival than patients with extracranial involvement
Presenter: Ariane Steindl
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast
289MO - Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: A large mono institutional experience
Presenter: Marta Padovan
Session: Mini Oral session: CNS tumours
Resources:
Abstract
Slides
Webcast